14 results · 20ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

ORTHOPANTOMOGRAPH OP 3D

FDA 510(k)
FDA Class 2 ·Radiology

QRS CARD S-T SEGMENT ANALYSIS PATIENT MONITORING SYSTEM MODEL: QRS CARD USB

FDA 510(k)
FDA Class 2 ·Cardiovascular

ACCUVIX V10 DIAGNOSTIC ULTRASOUND SYSTEM

FDA 510(k)
FDA Class 2 ·Radiology

AMISTEM-H HA COATED STD STEM SIZE 3

FDA Adverse Event
Injury ·MEDACTA INTERNATIONAL SA·Product code LZO·December 29, 2017

UNISYN HIP SYSTEM

FDA Adverse Event
Injury ·CONSENSUS ORTHOPEDICS, INC.·Product code LPH·August 26, 2019

OMNIPOD INSULIN PUMP

FDA Adverse Event
Malfunction ·INSULET CORPORATION·Product code LZG·May 23, 2013

TOTALCARE-

FDA Adverse Event
Malfunction ·HILL-ROM INC.·Product code FNL·June 22, 2011

PLUM A+ PUMP

FDA Adverse Event
Malfunction ·HOSPIRA, INC.·Product code FRN·September 15, 2008

MENTOR CPX 4 BREAST TISSUE EXPANDER WITH SUTURE TABS

FDA Adverse Event
Malfunction ·MENTOR TEXAS·Product code LCJ·October 20, 2020

MENTOR CPX 4 BREAST TISSUE EXPANDER

FDA Adverse Event
Injury ·MENTOR TEXAS·Product code LCJ·May 24, 2022

MENTOR CPX 4 BREAST TISSUE EXPANDER

FDA Adverse Event
Injury ·MENTOR TEXAS·Product code LCJ·June 27, 2024

MENTOR CPX 4 BREAST TISSUE EXPANDER

FDA Adverse Event
Injury ·MENTOR TEXAS·Product code LCJ·December 9, 2022

CADD-Solis VIP ambulatory Infusion Pumps, Model 2110. Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.

FDA Enforcement
Class I ·Ongoing·Smiths Medical ASD Inc.·August 14, 2024

cobas 6000 Modular Series system; Part Numbers: 1. 04745914001 cobas c 501 module; 2. 05036453001 cobas 6000 UL c 501 + Core Fix configuration; 3. 05036453692 - cobas 6000 UL + CORE CU; and 4. 05860636001 cobas 6000 c 501 (UL) V

FDA Enforcement
Class II ·Terminated·Roche Diagnostics Corporation·March 14, 2018